Johnson & Johnson’s medical devices helped to offset an otherwise disappointing quarterly report for the company. The firm said its orthopedic-products unit faced pricing pressures in the United States and Europe, particularly for its spinal devices. J&J also expects its surgical-procedure products to lead some of the favorable trends it sees for the device sector. The DePuy subsidiary was considered especially vulnerable to hospital cost-cutting, leading to tougher negotiations for lower prices for devices. (Click here for more)
“J&J Sends Mixed Signals About Medical-Device Sector Trends” – Nasdaq (Dow Jones) (7/20/10)
Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

